InfuSystem Holdings (INFU) Operating Income Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 156.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.42% |
| Dec 31, 2025 | 53.39% |
| Sep 30, 2025 | 59.29% |
| Jun 30, 2025 | 163.26% |
| Mar 31, 2025 | 47.01% |
| Dec 31, 2024 | 17.76% |
| Sep 30, 2024 | 124.41% |
| Jun 30, 2024 | 38.65% |
| Mar 31, 2024 | -43.71% |
| Dec 31, 2023 | 6.49% |
| Sep 30, 2023 | -19.50% |
| Jun 30, 2023 | -34.82% |
| Mar 31, 2023 | -73.72% |
| Dec 31, 2022 | -7.76% |
| Sep 30, 2022 | -17.23% |
| Jun 30, 2022 | -40.26% |
| Mar 31, 2022 | -7.72% |
| Dec 31, 2021 | 133.40% |
| Sep 30, 2021 | -54.59% |
| Jun 30, 2021 | 75.57% |